RANBP9
Basic information
Region (hg38): 6:13621498-13711835
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RANBP9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 42 | 42 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 42 | 1 | 0 |
Variants in RANBP9
This is a list of pathogenic ClinVar variants found in the RANBP9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-13622372-T-C | not specified | Uncertain significance (Aug 16, 2021) | ||
6-13622397-A-C | not specified | Uncertain significance (Jan 24, 2024) | ||
6-13622414-C-T | not specified | Uncertain significance (May 27, 2022) | ||
6-13625691-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
6-13632397-C-G | not specified | Uncertain significance (Jul 05, 2023) | ||
6-13632434-T-C | not specified | Uncertain significance (Jul 16, 2021) | ||
6-13632453-G-T | not specified | Uncertain significance (May 23, 2023) | ||
6-13632490-C-A | not specified | Uncertain significance (Jun 16, 2024) | ||
6-13634448-T-G | not specified | Uncertain significance (May 25, 2022) | ||
6-13634458-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
6-13634545-C-T | not specified | Uncertain significance (Nov 07, 2023) | ||
6-13637877-G-C | not specified | Uncertain significance (Jun 18, 2021) | ||
6-13639595-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
6-13639652-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
6-13639748-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
6-13644550-T-C | not specified | Uncertain significance (May 08, 2024) | ||
6-13644641-T-C | not specified | Uncertain significance (Dec 19, 2023) | ||
6-13644663-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
6-13652689-G-A | Likely benign (Nov 17, 2017) | |||
6-13657117-T-C | not specified | Uncertain significance (Jun 10, 2022) | ||
6-13710974-T-C | not specified | Uncertain significance (Apr 01, 2024) | ||
6-13711009-G-A | not specified | Uncertain significance (May 30, 2024) | ||
6-13711027-T-G | not specified | Uncertain significance (Jul 09, 2021) | ||
6-13711106-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
6-13711110-G-C | Likely benign (Oct 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RANBP9 | protein_coding | protein_coding | ENST00000011619 | 14 | 90067 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000108 | 118838 | 0 | 1 | 118839 | 0.00000421 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.49 | 258 | 335 | 0.771 | 0.0000165 | 4683 |
Missense in Polyphen | 103 | 169.01 | 0.60941 | 1989 | ||
Synonymous | -1.63 | 144 | 121 | 1.19 | 0.00000639 | 1451 |
Loss of Function | 5.45 | 1 | 36.5 | 0.0274 | 0.00000209 | 430 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000566 | 0.0000566 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.0000566 | 0.0000566 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May act as scaffolding protein, and as adapter protein to couple membrane receptors to intracellular signaling pathways (Probable). Acts as a mediator of cell spreading and actin cytoskeleton rearrangement (PubMed:18710924). Core component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1 (PubMed:29911972). May be involved in signaling of ITGB2/LFA- 1 and other integrins (PubMed:14722085). Enhances HGF-MET signaling by recruiting Sos and activating the Ras pathway (PubMed:12147692). Enhances dihydrotestosterone-induced transactivation activity of AR, as well as dexamethasone-induced transactivation activity of NR3C1, but not affect estrogen-induced transactivation (PubMed:12361945, PubMed:18222118). Stabilizes TP73 isoform Alpha, probably by inhibiting its ubiquitination, and increases its proapoptotic activity (PubMed:15558019). Inhibits the kinase activity of DYRK1A and DYRK1B. Inhibits FMR1 binding to RNA. {ECO:0000269|PubMed:12147692, ECO:0000269|PubMed:12361945, ECO:0000269|PubMed:14500717, ECO:0000269|PubMed:14722085, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:15558019, ECO:0000269|PubMed:18222118, ECO:0000269|PubMed:18710924, ECO:0000269|PubMed:29911972, ECO:0000305}.;
- Pathway
- Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;Developmental Biology;Signal Transduction;AndrogenReceptor;BDNF;Coregulation of Androgen receptor activity;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;L1CAM interactions;Axon guidance;MET activates RAS signaling;Signaling by MET;Signaling by Receptor Tyrosine Kinases;Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
(Consensus)
Recessive Scores
- pRec
- 0.206
Intolerance Scores
- loftool
- 0.0392
- rvis_EVS
- -0.76
- rvis_percentile_EVS
- 13.45
Haploinsufficiency Scores
- pHI
- 0.771
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.605
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.806
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ranbp9
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- ranbp9
- Affected structure
- Muller cell
- Phenotype tag
- abnormal
- Phenotype quality
- absent
Gene ontology
- Biological process
- MAPK cascade;microtubule nucleation;axon guidance;protein-containing complex assembly;negative regulation of ERK1 and ERK2 cascade
- Cellular component
- ubiquitin ligase complex;nucleus;cytoplasm;cytosol;microtubule associated complex;plasma membrane
- Molecular function
- Ras guanyl-nucleotide exchange factor activity;protein binding;Ran GTPase binding;enzyme binding